Why is Senores Pharma. falling/rising?

As of 07-Jul, Senores Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 574.40, reflecting a rise of 7.3 points or 1.29%. Today's price summary indicates that the stock has outperformed its sector by 0.71% and has gained after four consecutive days of decline, reaching an intraday high of Rs 578.5. Despite this positive movement, the stock has shown a negative return of -1.64% over the past week, although it has increased by 7.76% over the past month. The company's low debt-to-equity ratio and impressive long-term growth in net sales and operating profit contribute positively to its performance. However, the stock faces challenges such as a flat result forecast for December 2024 and a high price-to-book value ratio, which may deter some investors. Additionally, a significant decrease in institutional investor participation, with a -10.3% reduction in their stake, raises concerns about the stock's future performance.
Broader Market Context: In comparison to the benchmark Sensex, which has seen a slight decline of -0.20% over the past week, Senores Pharmaceuticals' short-term performance has been relatively weak. While the stock has outperformed the benchmark in the short term, its year-to-date return of +0.97% is notably lower than the Sensex's +6.79%. This context suggests that while the stock is currently rising, it is still lagging behind broader market trends, which may influence investor sentiment moving forward.